Diversified Healthcare Trust DHC
8.13
0.01
0.12%
as of 25 Sep
- Market cap
- $2.0B
- P/E
- 0.0×
Follow DHC
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
1.49 | 1.05 | 0.76 | 0.69 | |
P/FCF ratio |
20.88 | 3.64 | 2.76 | 5.49 | |
P/Operating CF |
58.33 | 191.58 | (57.95) | (21.51) | |
P/B ratio |
1.41 | 0.99 | 0.70 | 0.63 | |
Price to Tangible BV |
1.41 | 0.99 | 0.70 | 0.63 | |
EV/Sales |
3.30 | 2.84 | 2.53 | 2.62 | |
EV/EBITDA |
30.79 | 29.85 | 28.85 | 29.06 | |
EV/Operating CF |
(218.59) | (536.52) | (198.51) | 215.33 | |
EV/FCF |
46.21 | 9.82 | 9.21 | 20.82 | |
Quick Ratio |
4.67 | 5.36 | 4.10 | 16.89 | |
Current Ratio |
4.67 | 5.36 | 3.97 | 16.89 | |
Net Debt/EBITDA |
35.22 | 37.36 | 38.13 | (105.97) | |
Debt/Assets |
56.69% | 56.28% | 55.05% | 58.14% | |
Debt/Equity |
1.52 | 1.48 | 1.44 | 1.61 | |
Asset Turnover |
0.33 | 0.33 | 0.32 | 0.31 | |
Operating CF/Net income |
(1.03) | (0.19) | 0.95 | 0.30 | |
Capex/Depreciation |
(0.26) | (0.54) | 2.81 | (0.30) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
5.29% | 3.83% | 3.30% | 3.29% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
(1.13) | (1.57) | (2.21) | (2.63) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(11.94%) | (20.03%) | (24.54%) | (33.11%) | |
Free Cash Flow Yield |
4.79% | 27.46% | 36.28% | 18.23% | |
Revenue per Share |
1.52 | 1.52 | 1.58 | 1.62 | |
Operating CF per Share |
0.16 | 0.03 | (0.08) | (0.20) | |
Capex per Share |
(0.07) | (0.15) | 0.86 | (0.11) | |
Free Cash Flow per Share |
0.09 | (0.11) | 0.78 | (0.31) | |
Cash per Share |
0.57 | 0.58 | 0.51 | 0.87 | |
Shareholders Equity per Share |
6.57 | 6.73 | 6.93 | 7.03 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
6.57 | 6.73 | 6.93 | 7.03 | |
Free Cash Flow |
21.33 | (26.82) | 187.31 | (74.57) | |
Working Capital |
107.00 | 113.77 | 91.12 | 197.22 | |
Capital Expenditures |
(17.06) | (35.17) | 207.42 | (25.28) | |
Net Current Asset Value |
(2,519.67) | (2,507.28) | (2,573.88) | (2,785.62) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.05 | 0.10 | (0.55) | 0.07 | |
Net Profit Margin |
(10.24%) | (11.81%) | (5.59%) | (42.20%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
— | — | 2.98 | — | |
Average Payables |
— | — | 15.48 | — | |
Average Assets |
4,497.57 | 4,631.70 | 4,749.13 | 4,984.59 | |
Average Common Equity |
1,718.90 | 1,784.24 | 1,812.21 | 1,868.57 |
Columns are period end dates